YAP1 and central nervous system cancer: The crosstalk between Hippo-YAP/TAZ and β-catenin signaling also occurs during brain development, in neurodegenerative disorders and in glioma pathogenesis (Ouyang et al., 2020; Sileo et al., 2022).